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Handled by Andreas KellerCalcium homeostasis is crucial for muscle
contractility
Muscle cells are critically dependent on calcium homeostasis.
Without having the right amount of calcium ions just on the
spot and coordinated in between muscle cells, no contraction
can take place. Therefore, calcium homeostasis is one of the
critical regulatory mechanisms in all muscle cells, including
skeletal muscle and heart [1,2]. Sarco-endoplasmic reticulum
Ca2+ adenosine triphosphatase (SERCA) is responsible for
the relaxation of muscle cells by pumping Ca2+ into the
sarcoplasmic reticulum (SR) [3,4]. For the process of muscle
contraction, not only excitation via calcium-release but also
the quick reestablishing of the baseline calcium gradient is
absolutely necessary. Proteins known to be involved in this
process include phospholamban (PLN; inhibition of SERCA
in phosphorylated state) [5–7], sarcolipin (SLN; uncoupling
of SERCA in heat regulation) [7–9], and myoregulin (MLN;
inhibition of skeletal muscle SERCA) [10].DWORF – a peptide ‘‘hiding’’ in a non-coding RNA
Recently Nelson et al. published a paper in Science [11],
describing their discovery of a so-far unknown small protein,
named dwarf open reading frame (DWORF), which could
function as an activator of SERCA [11]. DWORF consists
of 34 amino acid residues and ‘‘is the third smallest full-length
protein known to be encoded by the mouse genome” [11].
Astonishingly, DWORF is encoded by a locus within the open
reading frame of a previously-annotated long non-coding
RNA (lncRNA) gene (‘‘NONMMUG026737” in mice, corre-
sponding to ‘‘LOC100507537” in humans). Notably, a similar
genomic structure is reported for the gene encoding MLN,
which is located within a previously-annotated lncRNA named
LINC00948 in humans [10].
To understand the impact of these findings, one must take a
look at the background of lncRNAs. lncRNAs are commonly
defined as RNAs that have more than 200 nucleotides in length
and appear not to have coding potential [12]. The length
distinguishes lncRNAs from small regulatory RNAs like
microRNAs, while it is clear that there is not always a clear
cut-off in discrimination to other RNA subtypes [13]. The
biological function of lncRNAs — without going into more
detail here — is not always easy to identify and seems to be
very diverse [14,15]. In the past years, many newly-described
so-called ‘‘lncRNA” have been published and it seems that
they have biological implication in animal models for differentnces and
180 Genomics Proteomics Bioinformatics 14 (2016) 179–180diseases, but their precise role mostly remains unclear [14,15].
In the aforementioned paper, the authors searched explicitly
for ‘‘masked” proteins inside areas previously described as
non-coding regions using a recognition software such as
PhyloCSF [16]. Doing so, they were able to detect protein-
coding information hidden in RNAs, which literally had been
‘‘thrown away” before. This is of course not true for every
lncRNA. As we understand too little about the functions of
lncRNAs in general, sometimes misleading interpretations as
described above can occur, making it crucial to understand
and divide this heterogeneous group of RNAs for correctly
analyzing their functional implications (e.g., regulatory roles).DWORF – increasing contractility by improving
relaxation
DWORF is conserved across species, which gives a glimpse at
the importance of this protein. Though it is expressed in the
heart and in slow-twitch muscle fibers, there is a lack of gene
expression of DWORF in fast-twitch muscle. Slow twitch mus-
cle cells contract slower and efficiently use oxygen for enduring
contraction purposes, while in contrast fast-twitch muscle cells
use preferably anaerobic pathways for short-term contractions
[17]. In other words, the DWORF regulates muscle cells
involved in long-term contractility such as the heart.
The authors confirmed the expression of the presumed
protein (e.g., by Western blotting) and showed that SERCA
and DWORF not only co-localize, but also interact. In other
words, DWORF activates SERCA using the same binding
domain as PLN with similar binding affinities. In tetanic stim-
ulated muscle cells, DWORF enhanced the relaxation time,
which could not be seen with lower stimulation frequencies.
Therefore, the authors conclude that DWORF might be a pos-
itive enhancer for re-compensation of muscle contractility after
tetanic stimulation by fast ‘‘filling” the pool of Ca2+ in SR.
This activation of SERCA is due to inhibition of PLN, which
itself inhibits the SERCA-mediated calcium flow, conclusive to
the finding that they act on the same binding site.
By performing further functional analysis, the authors
showed that DWORF is an indirect activator of SERCA. With
overexpression of DWORF, transgenic mice showed an
increased influx into SR. Consecutively, the contractility in
these mice was significantly higher due to a higher relaxation
rate and higher load of Ca2+ inside SR.
From the physicians’ point of view, the question remains
how this finding could be translated into novel therapies. In
their paper, the authors show a downregulation of DWORF
not only in the dilated cardiomyopathy (DCM) mice but also
in failing human hearts [11]. Currently, the baseline therapy
for patients with a failing heart is to minimize workload and
protect it from pathological stress. Combining the findings of
the paper, there are two possibilities taking benefit out of
these: First, DWORF could be used as a new biomarker in
DCM patients showing the loss of contractility and therefore
the severity of the heart failure state in general. This could give
physicians the opportunity to optimize therapy before the
patient is showing a deteriorated clinical course. Second,
DWORF can be considered as a new drug target. By activating
or increasing the amount of DWORF in heart failing muscle
cells, the contractility could be raised by activating SERCA.
This would be a new therapeutic way, which would go handin hand with the baseline therapy of patients with severe heart
failure.
In summary, the search for proteins ‘‘hidden in the black
space of the genome” will certainly lead to novel surprises as
to the complexity of the human heart. Bioinformatics methods
are the first stage in this exciting discovery process.
Competing interests
The authors declare that they have no competing interests.Acknowledgments
DO and JH are supported by the German Centre for
Cardiovascular Research (DZHK) and the German Ministry
of Education and Research (BMBF).
References
[1] Bers DM. Calcium fluxes involved in control of cardiac myocyte
contraction. Circ Res 2000;87:275–81.
[2] Braveny´ P. Heart, calcium and time. Exp Clin Cardiol 2002;7:3–6.
[3] Periasamy M, Kalyanasundaram A. SERCA pump isoforms:
their role in calcium transport and disease. Muscle Nerve
2007;35:430–42.
[4] Wuytack F, Raeymaekers L, Missiaen L. Molecular physiology of
the SERCA and SPCA pumps. Cell Calcium 2002;32:279–305.
[5] Espinoza-Fonseca LM, Autry JM, Ramirez-Salinas GL, Thomas
DD. Atomic-level mechanisms for phospholamban regulation of
the calcium pump. Biophys J 2015;108:1697–708.
[6] Frank K, Kranias EG. Phospholamban and cardiac contractility.
Ann Med 2000;32:572–8.
[7] MacLennan DH, Asahi M, Tupling AR. The regulation of
SERCA-type pumps by phospholamban and sarcolipin. Ann N Y
Acad Sci 2003;986:472–80.
[8] Fajardo VA, Bombardier E, Vigna C, Devji T, Bloemberg D,
Gamu D, et al. Co-expression of SERCA isoforms, phospholam-
ban and sarcolipin in human skeletal muscle fibers. PLoS One
2013;8:e84304.
[9] Shaikh SA, Sahoo SK, Periasamy M. Phospholamban and
sarcolipin: Are they functionally redundant or distinct regulators
of the Sarco(Endo)Plasmic Reticulum Calcium ATPase? J Mol
Cell Cardiol 2016;91:81–91.
[10] Anderson DM, Anderson KM, Chang CL, Makarewich CA,
Nelson BR, McAnally JR, et al. A micropeptide encoded by a
putative long noncoding RNA regulates muscle performance. Cell
2015;160:595–606.
[11] Nelson BR, Makarewich CA, Anderson DM, Winders BR,
Troupes CD, Wu F, et al. A peptide encoded by a transcript
annotated as long noncoding RNA enhances SERCA activity in
muscle. Science 2016;351:271–5.
[12] Kung JTY, Colognori D, Lee JT. Long noncoding RNAs: past,
present, and future. Genetics 2013;193:651–69.
[13] Rinn JL, Chang HY. Genome regulation by long noncoding
RNAs. Ann Rev Biochem 2012;81:145–66.
[14] Cao J. The functional role of long non-coding RNAs and
epigenetics. Biol Proced Online 2014;16:11.
[15] Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs:
functional surprises from the RNA world. Genes Dev
2009;23:1494–504.
[16] Lin MF, Jungreis I, Kellis M. PhyloCSF: a comparative genomics
method to distinguish protein coding and non-coding regions.
Bioinformatics 2011;27:i275–82.
[17] Schiaffino S, Reggiani C. Fiber types in mammalian skeletal
muscles. Physiol Rev 2011;91:1447–531.
